Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Motorsport Games Earnings Perspective: Return On Capital Employed

Benzinga Pro data, Motorsport Games (NASDAQ:MSGM) reported Q4 sales of $8.22 million. Earnings fell to a loss of $7.00 million, resulting in a 5.12% decrease from last quarter.

Benzinga

Berry (bry)'s Return On Capital Employed Insights

Pulled from Benzinga Pro data, Berry (bry) (NASDAQ:BRY) showed a loss in earnings since Q3, totaling $8.82 million. Sales, on the other hand, increased by 45.09% to $208.09 million during Q4.

Benzinga

Angion Biomedica's Return On Capital Employed Insights

According to Benzinga Pro, during Q4, Angion Biomedica (NASDAQ:ANGN) earned $14.89 million, a 194.82% increase from the preceding quarter. Angion Biomedica also posted a total of $25.94 million in sales, a 1676.78% increase since Q3.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Bolt Biotherapeutics's Return On Capital Employed Overview

Bolt Biotherapeutics (NASDAQ:BOLT) brought in sales totaling $508.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 16.08%, resulting in a loss of $27.16 million.

Benzinga

Looking Into Icosavax's Return On Capital Employed

According to Benzinga Pro data, during Q4, Icosavax (NASDAQ:ICVX) posted sales of $2.07 million. Earnings were up 47.12%, but Icosavax still reported an overall loss of $18.18 million.

Benzinga

U.S. Well Servs's Return On Capital Employed Insights

Benzinga Pro data, U.S. Well Servs (NASDAQ:USWS) reported Q4 sales of $38.93 million. Earnings fell to a loss of $22.74 million, resulting in a 137.44% decrease from last quarter. U.S.

Benzinga

Benzinga's Daily Brief On Trending Tickers For March 31, 2022: Hasbro, Amazon, GameStop And More

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks. The data on the trending tickers is compiled from a list of most-discussed tickers on the popular Reddit forum WallStreetBets.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Looking Into Miromatrix Medical's Return On Capital Employed

Benzinga Pro data, Miromatrix Medical (NASDAQ:MIRO) reported Q4 sales of $8.00 thousand. Earnings fell to a loss of $5.48 million, resulting in a 8.27% decrease from last quarter.

Benzinga

Acutus Medical Earnings Perspective: Return On Capital Employed

Acutus Medical (NASDAQ:AFIB) brought in sales totaling $4.36 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 9.66%, resulting in a loss of $31.26 million.

Benzinga

Looking Into PolarityTE's Return On Capital Employed

Benzinga Pro data, PolarityTE (NASDAQ:PTE) reported Q4 sales of $1.04 million. Earnings fell to a loss of $8.57 million, resulting in a 739.18% decrease from last quarter.

Benzinga

ATAI Life Sciences's Return On Capital Employed Insights

ATAI Life Sciences (NASDAQ:ATAI) brought in sales totaling $230.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 194.78%, resulting in a loss of $93.27 million.

Benzinga

Five Below Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q4, Five Below (NASDAQ:FIVE) earned $140.20 million, a 479.87% increase from the preceding quarter. Five Below also posted a total of $996.33 million in sales, a 63.97% increase since Q3.

Benzinga

Arhaus Earnings Perspective: Return On Capital Employed

According to Benzinga Pro data Arhaus (NASDAQ:ARHS) posted a 55.84% decrease in earnings from Q3. Sales, however, increased by 17.16% over the previous quarter to $238.23 million.

Benzinga

Why Longeveron Shares Are Surging Today

Longeveron Inc (NASDAQ: LGVN) shares are trading higher Thursday after the company announced the publication of results from a Phase 1 trial testing Lomecel-B on patients with mild Alzheimer's disease in "Alzheimer's & Dementia: The Journal of the Alzheimer's Association."

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Agile Therapeutics's Return On Capital Employed Insights

Benzinga Pro data, Agile Therapeutics (NASDAQ:AGRX) reported Q4 sales of $1.51 million. Earnings fell to a loss of $23.36 million, resulting in a 39.26% decrease from last quarter.

Benzinga

Motus GI Hldgs's Return On Capital Employed Overview

According to data from Benzinga Pro, during Q4, Motus GI Hldgs's (NASDAQ:MOTS) reported sales totaled $99.00 thousand. Despite a 0.12% increase in earnings, the company posted a loss of $4.82 million.

Benzinga

vTv Therapeutics's Return On Capital Employed Overview

vTv Therapeutics (NASDAQ:VTVT) brought in sales totaling $9.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 547.3%, resulting in a loss of $9.48 million.

Benzinga

Here's How This Bitcoin Mining Company Fared In FY21

Bitcoin mining company Sphere 3D Corp (NASDAQ:ANY) reported an FY21 revenue decline of 23.3% year-on-year to $3.72 million. The gross margin contracted 80 bps to 45.6%. Operating expenses more than doubled to $21.4 million. EPS loss was $(0.58) versus $(0.98) last year. Sphere 3D held $54.4 million in cash and equivalents. CEO Peter Tassiopoulos…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Celsion: Q4 Earnings Insights

Celsion (NASDAQ:CLSN) reported its Q4 earnings results on Thursday, March 31, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Bassett Furniture Q1 Earnings

Bassett Furniture Indus (NASDAQ:BSET) reported its Q1 earnings results on Thursday, March 31, 2022 at 09:00 AM. Here's what investors need to know about the announcement.

Benzinga

Galectin Therapeutics: Q4 Earnings Insights

Galectin Therapeutics (NASDAQ:GALT) reported its Q4 earnings results on Thursday, March 31, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Acacia Research Stock Gains On Record Q4 Results, New Buyback

Acacia Research Corp (NASDAQ:ACTG) reported fourth-quarter revenues of $63.3 million compared to $4.4 million in 4Q20. The company's Intellectual Property business generated $51.3 million in licensing and other revenue versus $4.4 million last year. Operating income recovered to $31.3 million from a loss of $(6.4) million a year ago. EPS was $0.45 compared…

Benzinga

Baidu, iQIYI Explore Options After US SEC Added Them To Provisional List Pending Audit Review

Baidu Inc (NASDAQ:BIDU) explored options after the U.S. SEC added the Chinese search engine giant to a list of companies that faced delisting concerns, Reuters reports. Beijing refused to permit U.S. officials to review their auditors' work, Bloomberg reports. A 2020 U.S. law mandated a three-year clock for firms to comply with inspection…

Benzinga

Clovis Oncology's Rubraca Significantly Improves PFS In Ovarian Cancer Regardless Of Biomarker Status

Clovis Oncology Inc (NASDAQ:CLVS) announced positive topline data from the monotherapy arm of Phase 3 ATHENA-MONO trial of Rubraca (Rucaparib) as first-line maintenance treatment in ovarian cancer. Rubraca achieved the primary endpoint of significantly improved progression-free survival (PFS) compared with placebo (20.2 months vs. 9.2 months). The median PFS for the HRD-positive patient…

Benzinga

Expert Ratings For JB Hunt Transport Servs

JB Hunt Transport Servs (NASDAQ:JBHT) has observed the following analyst ratings within the last quarter:

1 … 769 770 771 772

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Places

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.